Regional DXA studies in a double blind placebo controlled trial of cyclical etidronate therapy for the prevention of early post-menopausal bone loss

Bone ◽  
1995 ◽  
Vol 17 (6) ◽  
pp. 611 ◽  
Author(s):  
R.J.M. Herd ◽  
G.M. Blake ◽  
P. Ryan ◽  
I. Fogelmam
Keyword(s):  
Bone Loss ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Cyclical Etidronate ◽  
Post Menopausal

scholarly journals Ibandronate Prevents Bone Loss and Reduces Vertebral Fracture Risk in Male Cardiac Transplant Patients: A Randomized Double-Blind, Placebo-Controlled Trial*

2009 ◽  
Vol 24 (7) ◽  
pp. 1335-1344 ◽  
Author(s):  
Astrid Fahrleitner-Pammer ◽  
Jutta Claudia Piswanger-Soelkner ◽  
Thomas Rudolf Pieber ◽  
Barbara Maria Obermayer-Pietsch ◽  
Stefan Pilz ◽  
...  
Keyword(s):  
Vertebral Fracture ◽  
Bone Loss ◽  
Fracture Risk ◽  
Controlled Trial ◽  
Cardiac Transplant ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Transplant Patients ◽  
Vertebral Fracture Risk

A Double Blind, Placebo-Controlled Trial of Ipriflavone for Prevention of Postmenopausal Spinal Bone Loss

1997 ◽  
Vol 61 (2) ◽  
pp. 142-147 ◽  
Author(s):  
D. Agnusdei ◽  
G. Crepaldi ◽  
G. Isaia ◽  
G. Mazzuoli ◽  
S. Ortolani ◽  
...  
Keyword(s):  
Bone Loss ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo

Efficacy and safety of Nigella sativa in the treatment of post-menopausal osteoporotic women: a randomized double-blind placebo-controlled trial

Maturitas ◽  
2015 ◽  
Vol 81 (1) ◽  
pp. 163
Author(s):  
Shirin Hasani-ranjbar ◽  
Hoda Zahedi ◽  
Hamideh Fakhraee ◽  
Eghbal Taheri ◽  
Bagher Laijani
Keyword(s):  
Nigella Sativa ◽  
Controlled Trial ◽  
Efficacy And Safety ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Post Menopausal
Sign in / Sign up

Export Citation Format

Share Document